Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-02-13
1991-06-04
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544182, A61K 3153, C07D25306
Patent
active
050214152
ABSTRACT:
Heterocyclic acids and esters useful as inhibitors of mammalian blood platelet aggregation characterized by Formula I or II are disclosed. ##STR1## Formula I compounds are those wherein n is 6-9, R is hydrogen, lower alkyl or an alkali metal ion, and HET.sub.1 is the heterocyclic radical 2,3-dihydro-3-oxo-5,6-diphenyl-1,2,4-triazin-2-yl.
Formula II compounds are those wherein R.sub.1 is hydrogen, lower alkyl or an alkali metal ion, and the radical --OCH.sub.2 CO.sub.2 R is attached in the 3 or 4 ring position; and HET.sub.2 is the heterocyclic radical 2,3-dihydro-3-oxo-5,6-diphenylmethyl-1,2,3-triazin-2-yl.
REFERENCES:
patent: 4167566 (1979-09-01), Petit et al.
patent: 4318911 (1982-03-01), Lacefield
patent: 4511566 (1985-04-01), Petit et al.
patent: 4677105 (1987-06-01), Guy et al.
patent: 4851411 (1989-07-01), Petit et al.
Bristol-Myers Squibb Co.
Ford John M.
Uloth Robert H.
LandOfFree
Triazine carboxylic acids and esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazine carboxylic acids and esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazine carboxylic acids and esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026514